Xxxxx Xxxxxxx and Xx Sample Clauses

Xxxxx Xxxxxxx and Xx. XXX Xxxx as non-executive Directors; Dr. XX Xxx Xxx, Xx. XX Xxxxxxxx and Xx. XXXX Xxxx Xxxx as executive Directors and Xx. XXXX Wing Xxxx, Xxxxxx, Xx. XXXX Xxxxxxx, Xx. XXX Xxxxxxx and Mr. XX Xx as independent non-executive Directors.
AutoNDA by SimpleDocs
Xxxxx Xxxxxxx and Xx. XXX Xxxx as non-executive Directors; Dr. XX Xxx Xxx, Xx. XX Xxxxxxxx and Xx. XXXX Xxxx Xxxx as executive Directors and Xx. XXXX Wing Xxxx, Xxxxxx, Xx. XXXX Xxxxxxx, Xx. XXX Xxxxxxx and Mr. XX Xx as independent non-executive Directors. If there is any inconsistency in this announcement between the Chinese and English versions, the English version shall prevail.
Xxxxx Xxxxxxx and Xx. Xxxx Xxxxxx (Mr. Xxxxx Xxx as his alternate) as non-executive Directors, and Xx. Xxxx Xxxx, Xx. Xxx Xxxxxx and Xx. Xxxx Xxxxx as independent non-executive Directors.
Xxxxx Xxxxxxx and Xx. Xxx Xxxxxxxx Xxxxxxx; and four independent non-executive directors of the Company, namely, Xx. Xxxxx Xxxx Xxx, Xx. Xx Xxxxxxxx, Xx. Xxx Xxxxxxxx and Xx. Xxxx Xxxx.
Xxxxx Xxxxxxx and Xx. Xxxxx Xxxxx (above) enter a new partnership as Xxxxx launches a company around Xxxxxxx’s compounds. commercialization of compounds in the U.S. and abroad, Xxxxx had experience in all steps of the drug development process, from drug inception, preclinical and clinical development, to manufacturing and commercialization. He agreed to develop a business plan to license the patent portfolio of his former professor and to help find someone to execute it. Even though he’d worked for many startups, he wasn’t expecting to start his own company. He’d known Xxxxxxx for years—in fact, Xxxxxxx, then department chair of my long-standing relationship with Duquesne, I feel that I have a duty, an obligation to do good by this opportunity,” says Xxxxx. “Drug development is a long, bumpy road that requires a tremendous amount of patience, dedication and know-how. It could be up to 2 ½ years before FLAG can advance an investigational compound through the first phases of development. Ultimately, the goal is to get these compounds into the hands of people who can benefit from new treatment options.” The Bigger Picture Behind the Big Deal A deal with a company like FLAG, whose sole focus is Xxxxxxx’s compounds, offers the best opportunity for the compounds to enter the marketplace, says Xx. Xxxx X. Seadler, associate xxxxxxx for research and technology. Plus, the pervasive Duquesne thread woven between Xxxxxxx and Xxxxx provides a special connection. the pharmacy’s graduate school, presented Xxxxx with his master’s hood in 1990. Xxxxx certainly was aware of Xxxxxxx’s anti-cancer research. “But the more I learned about the work, the more intrigued I was,” says Xxxxx. “The small compounds were very intelligently designed and the strong patent portfolio around the work was incredibly impressive.” In June 2013, Xxxxx became founding president and CEO of FLAG Therapeutics Inc., creating a company around Xxxxxxx’s portfolio and making his relationship with Duquesne stronger than ever. Duquesne had provided Xxxxx’x academic foundation for three of his four degrees: pharmacy (’87, ’90) and an MBA in management (’90) from the School of Business, where son Xxxxx is a student. The pharmacy and MBA degrees were unusual combinations at the time, and Xxxxx discovered a love for the business of science. His Duquesne training, topped by a Ph.D. in pharmaceutical sciences from the University of Pittsburgh, set the stage for a varied career: as vice president of global science and technology at ...
Xxxxx Xxxxxxx and Xx. Xxx Xxxxxx for reading the finished manuscript and for their participation in the doctoral defense. I am also grateful for the many years of administrative assistance—and moral support—that I received from Xxxxxxx Xxxxxxxx, Xxxxxxxxx Xxxx, Xxxxxxx Xxxxxx, Xxxxxx Xxxxxx and Xxxxx Xxxxxx. This work is the result of many years spent studying the history of philosophy, an endeavor to which I would gladly devote myself many times over. Certain professors, at both Emory University and Loyola Marymount University, have been instrumental in this pursuit, and I would like to extend thanks to each of them for instilling in me the value of the historical approach to the discipline: Xx. Xxxxxx Xxxxxxx and the late Xxxxxx Xxxxxxx (Ancient); Xxxx Xxxx Xxxxxx, C.S.J and Xx. Xxxx Xxxxx (Medieval); Xx. Xxxxxx Xxxxxxxxxx, Xx. Xxxxxx Xxxxxx and Dr. Xxxxxxx Xxxxxx (Renaissance/Modern); and Xxxxxxx Xxxxxx (20th Century). Though writing a dissertation can be a solitary journey, I have been fortunate over the years to be surrounded by friends and family members who have supported me in this endeavor, both professionally and personally. Xxxxxxxxx Xxxxxx, Xxxxxx Xxxxxx xx Xxxxxxx and Xxxxxxxx Xxxxxx, in particular, offered much intellectual and moral support as I progressed towards a finished manuscript. They epitomize Xxxxxx’s observation that “a true friend is, as it were, a second self,” and I am grateful for their companionship. Finally, I would like to thank my parents, Xxxxxxxxxxx and Xxxxx Xxxx, and my sister, Xxxxxxx Xxxx, for their assistance and encouragement, which has spanned almost two decades of studying philosophy. Their faith in my philosophical vocation has been unparalleled. I also thank my husband, Xxxxxxx Xxxxx, for his unconditional support in achieving this goal. He has surpassed all expectations that one might hope for in a spouse. Last, but certainly not least, I dedicate this work to my two daughters, my unknowing muses in all things—past, present and future. March 2016 CONTENTS
Xxxxx Xxxxxxx and Xx. Xxx Xxxxxxxx; and the independent non- executive Directors are Xx. Xxx Xxxxxxx, Xx.
AutoNDA by SimpleDocs
Xxxxx Xxxxxxx and Xx. Xxxx Xxxxxxxx; the non-executive Directors are Xx. Xxxx Xxxxx, Xx.
Xxxxx Xxxxxxx and Xx. Xxxxxxxxx Xxxxxx for their patience in the face of indecision and continued willingness to serve on this committee. Introduction 1 Conceptualizing “Organized Crime” 4 Criminal Group Behavior & Illicit Market Foundations 7 Common Modes of Revenue Generation 7 Defining Behavioral Characteristics 10 The Role of the State 16 Defining Responsibilities of the State 16 How Do Organized Crime Groups Come to Exist? Theory & Hypotheses 19 Data 27 Operationalizing “Organized Crime Presence” 27 Explanatory Variables 30 Control Variables 39 Model Specification 43 Results 44 Endogeneity & Two-Stage Least Squares Regression 49 Discussion & Implications 57 Appendix A: Cultural Conservatism Index 60 Appendix B: Expanded Fixed Effects Regressions 61 Appendix C: Expanded Random Effects Regressions 62 Appendix D: Countries Included in Panel 63 References 64 Figure 1: WEF Organized Crime Score by Country, 2016 30 Table 1: Correlation: Components of Cultural Conservatism Index (CCI) 33 Table 2: Comparison of CIM Summary Statistics 34 Table 3: Correlation: CIM Datasets 35 Table 4: Alpha Value: CIM Datasets 35 Table 5: Correlation: Survey Measures of Trust in Police Services 38 Table 6: Descriptive Statistics 41 Table 7: Explanatory and Control Variables 42 Table 8: Diagnostic Tests 44 Table 9: Selected Fixed Effects Models 45 Table 10: Correlation: Explanatory Variables and Full-Model Fixed Effects Residuals 50 Figure 2: Residual Plots for CIM, CCI, Tax Revenue, Trust 51 Figure 3: Instrumental Variable Pathway 53 Table 11: Two-Stage Least Squares Regression 54 Introduction Since the Great Recession of 2008, organized crime groups across the globe have expanded aggressively, capitalizing on the insecurity engendered by crippling austerity measures (Naim 2012). This troubling trend warrants a systematic re-examination of the root causes of organized crime growth. Without a clear understanding of why organized crime groups gain power, interdiction is little more than a fool’s errand. Since antiquity, organized crime groups have vexed state authorities, providing the body politic with in-demand goods and services, deploying intimidation and violence, and otherwise undermining the rule of law. Yet, despite the enduring nature of this battle, effective countermeasures remain sparse. Organized crime groups (OCGs) do not emerge in isolation, and scholars must take empirical steps to understand what sort of environments are favorable to the growth of illicit organizations. For decades, a...
Xxxxx Xxxxxxx and Xx. Xxxxx Xxx as executive Directors, and Xx. Xxx Xxxxxx, Xx. Xxxx Xxxxxxx and Xx. Xx Xxxxxxxxx as
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!